Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party o
about
Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinibHematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age GroupsThe indications for allogeneic stem cell transplantation in myeloid malignancies.Ruxolitinib: long-term management of patients with myelofibrosis and future directions in the treatment of myeloproliferative neoplasmsMPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosismiR-181a modulates acute myeloid leukemia susceptibility to natural killer cells.New Strategies in Myeloproliferative Neoplasms: The Evolving Genetic and Therapeutic Landscape.Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?Current Challenges in Stem Cell Transplantation in Myelofibrosis.Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia.Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?Longer delay of hematological recovery and increased transfusion needs after haploidentical compared to non-haploidentical stem cell transplantation.Innate immune cells for immunotherapy of autoimmune and cancer disorders.Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.Safety and outcome of allogeneic stem cell transplantation in myelofibrosis.
P2860
Q26750696-328E3FB4-3FD1-4BDB-A0DA-BEFC188585BEQ26786893-ABF9EABD-3EB1-4302-99AB-DA4B1B68F002Q30316611-A08F074B-CFF9-41C7-B7B2-F8268899385EQ33417217-7F86A479-7F21-4F3E-B03A-CBE8F3ED3F48Q34047897-469E3367-2431-48C8-B953-4D18CC7E2968Q36256357-952C66F1-62F9-495A-9110-4A891E860889Q36782943-48A26A85-A1A6-487F-9414-2D83FEA9A9A6Q38349213-95562E5C-212E-423C-834A-7028BF449F78Q38569146-831CAC3B-BB13-4082-B120-0138637C6F36Q38570614-626CB01E-6AD3-4F7A-ADBD-1A49397E2C0BQ38603384-E316120C-BAF1-4F71-AE56-8858286B8078Q40261233-447B86AE-AAB2-41BE-B15D-B2837FC1A084Q40819256-7E35D94D-A016-4CE1-A07D-1B34C029D270Q48316500-C3D9384A-365F-462B-8E31-9E4B3E134D67Q55025278-FEF53520-E8E3-4C7C-87A8-FA81C291C44FQ55060741-84154DFB-5C75-4AD9-9386-D1BCF9C88369
P2860
Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party o
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Allogeneic hematopoietic stem ...... c Malignancies Working Party o
@ast
Allogeneic hematopoietic stem ...... c Malignancies Working Party o
@en
Allogeneic hematopoietic stem ...... c Malignancies Working Party o
@nl
type
label
Allogeneic hematopoietic stem ...... c Malignancies Working Party o
@ast
Allogeneic hematopoietic stem ...... c Malignancies Working Party o
@en
Allogeneic hematopoietic stem ...... c Malignancies Working Party o
@nl
prefLabel
Allogeneic hematopoietic stem ...... c Malignancies Working Party o
@ast
Allogeneic hematopoietic stem ...... c Malignancies Working Party o
@en
Allogeneic hematopoietic stem ...... c Malignancies Working Party o
@nl
P2093
P2860
P921
P1433
P1476
Allogeneic hematopoietic stem ...... c Malignancies Working Party o
@en
P2093
Alessandra Carobbio
Alessandro Rambaldi
Anja van Biezen
Arnon Nagler
Eduardo Olavarria
Elena Oldani
Jurgen Finke
Maria Chiara Finazzi
Marijke Scholten
Mauricette Michallet
P2860
P304
P356
10.3324/HAEMATOL.2013.094284
P577
2014-01-03T00:00:00Z